Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Tracking America's Recovery
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Hologic Inc
(NASDAQ:HOLX)
75.76
Delayed Data
As of Jan 22
-0.16
/
-0.21%
Today’s Change
26.49
Today
|||
52-Week Range
81.80
+4.02%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest HOLX News
|
Press Releases
Intuitive Surgical (ISRG) Q4 Earnings Beat Estimates, Up Y/Y
Jan 22 / Zacks.com - Paid Partner Content
Quest Diagnostics (DGX) COVID-19 Test Sales Solid, Volume Dull
Jan 18 / Zacks.com - Paid Partner Content
Can Diagnostics Aid Hologic (HOLX) Q1 Sales Amid Coronavirus?
Jan 22 / Zacks.com - Paid Partner Content
Intersect ENT's (XENT) Q4 Preliminary Revenues Disappointing
Jan 18 / Zacks.com - Paid Partner Content
Top Ranked Growth Stocks to Buy for January 21st
Jan 22 / Zacks.com - Paid Partner Content
NEOGEN's (NEOG) New Test to Aid in Detecting Cancer-Causing Toxin
Jan 18 / Zacks.com - Paid Partner Content
6 Stocks Trading Near 52-Week Highs That Can Rally Further
Jan 22 / Zacks.com - Paid Partner Content
Masimo (MASI) Reports Encouraging 2020 Preliminary Results
Jan 15 / Zacks.com - Paid Partner Content
Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know
Jan 20 / Zacks.com - Paid Partner Content
Integra (IART) Preliminary Q4 Reported Sales Show Recovery
Jan 15 / Zacks.com - Paid Partner Content
Why You Should Retain Pacific Biosciences (PACB) Stock Now
Jan 20 / Zacks.com - Paid Partner Content
Hologic (HOLX) Dips More Than Broader Markets: What You Should Know
Jan 14 / Zacks.com - Paid Partner Content
Masimo's (MASI) iSirona to Boost Hospital Automation Platform
Jan 20 / Zacks.com - Paid Partner Content
Exact Sciences (EXAS) Posts Solid Preliminary Q4 Testing Revenues
Jan 14 / Zacks.com - Paid Partner Content
3 Biggest MedTech Trends to Watch in 2021 for Better Returns
Jan 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics
Jan 14 / Zacks.com - Paid Partner Content
Want More Returns? Invest in Stocks With Momentum Anomaly
Jan 20 / Zacks.com - Paid Partner Content
Has Hologic (HOLX) Outpaced Other Medical Stocks This Year?
Jan 14 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic
Jan 20 / Zacks.com - Paid Partner Content
Top Ranked Growth Stocks to Buy for January 14th
Jan 14 / Zacks.com - Paid Partner Content
3 Lesser-Known Growth Stocks Rated Strong Buy: Hologic, PTC, and Par Technology
Jan 19 / StockNews.com - Paid Partner Content
OPKO Health's (OPK) BioReference Extends Digital Health Access
Jan 14 / Zacks.com - Paid Partner Content
Federal, Private Tie-Ups Boost COVID-19 Testing Volume
Jan 19 / Zacks.com - Paid Partner Content
Thermo Fisher (TMO) Rides on End Market Growth Amid Pandemic
Jan 14 / Zacks.com - Paid Partner Content
Here's Why You Should Add Hologic (HOLX) to Your Portfolio
Jan 19 / Zacks.com - Paid Partner Content
Testing Space in Focus Again Thanks to New Wave of Coronavirus
Jan 13 / Zacks.com - Paid Partner Content
Omnicell (OMCL) Reports Encouraging 2020 Preliminary Results
Jan 19 / Zacks.com - Paid Partner Content
STERIS (STE) to Expand Product Suite Via Cantel Medical Buyout
Jan 13 / Zacks.com - Paid Partner Content
Cardiovascular Systems' (CSII) OAS Gets CE Mark for Use in Europe
Jan 19 / Zacks.com - Paid Partner Content
Here is Why Growth Investors Should Buy Hologic (HOLX) Now
Jan 12 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Hits New 52-Week High: What's Driving It?
Jan 18 / Zacks.com - Paid Partner Content
Myriad Genetics (MYGN), Illumina Partner to Enhance Oncology Arm
Jan 12 / Zacks.com - Paid Partner Content